1. Introduction {#sec0005}
===============

Tobacco smoking is the leading preventable cause of death and disease worldwide, killing over seven million people annually ([@bib0220]). In many countries, increasingly comprehensive tobacco control policies have been implemented with the aim of "denormalizing" smoking and reducing smoking prevalence ([@bib0035]; [@bib0055]). However, the nicotine market has changed with the introduction of vaping devices (also called e-cigarettes; [@bib0125]) and there has been considerable discussion with regards to the impact of vaping on smoking norms and behavior. Vaping devices have the potential to reduce the harms caused by smoking and may help some smokers quit ([@bib0090]; [@bib0155]). However, concerns have been expressed that e-cigarettes might "renormalize" and promote smoking, particularly among youth ([@bib0010]; [@bib0170]; [@bib0175]; [@bib0190]). Studies are therefore needed to assess social norms towards smoking and vaping among youth, particularly cross-product associations between norms and behavior.

Social norms can be classified into two domains: descriptive and injunctive. Descriptive norms refer to perceptions of how others behave (e.g., friend smoking), while injunctive norms refer to perceptions of what others think people should or should not do (e.g., peer approval of smoking) ([@bib0020]; [@bib0040]). Associations between descriptive and injunctive norms and youth smoking are well documented: youth who have more friends or peers who smoke ([@bib0030]; [@bib0050]; [@bib0145]) or who perceive greater approval of smoking among parents, friends, or peers ([@bib0030]; [@bib0145]; [@bib0195]) are more likely to initiate smoking. Moreover, cross-sectional studies in the US and Mexico have found that youth with friends who vape and who perceive acceptability of vaping among peers are more susceptible to (i.e., open to trying in the next year), and more likely to actually try, vaping ([@bib0080]; [@bib0150]; [@bib0180]).

It is less clear whether there are cross-product influences of norms on product use. In Mexico and Argentina, friend smoking was more common among youth who have tried and are susceptible to vaping ([@bib0150]; [@bib0165]; [@bib0180]); however, no association was found between friend vaping, or perceived social acceptability of vaping, and smoking susceptibility ([@bib0150]). By contrast, a longitudinal study in Britain found that youth with vaping friends had greater odds of initiating vaping but lower odds of initiating smoking, while those who perceived public approval of smoking had lower odds of initiating vaping ([@bib0060]). It is therefore possible that norms towards one product may suppress, rather than promote, use of the alternative. Further research is required to corroborate these findings, particularly across countries with different smoking and vaping environments.

Research suggests that adult smokers and ex-smokers from countries with stronger tobacco control policies have more anti-smoking injunctive norms ([@bib0095]; [@bib0135]), while those from countries with less restrictive vaping policies have more pro-vaping norms ([@bib0005]). By contrast, a recent survey of smokers in Europe ([@bib0065]) found that while friend smoking was more common in countries with greater smoking prevalence and weaker tobacco control policies, approval of smoking was not, and friend vaping and approval of vaping showed little obvious relation to vaping prevalence or policies. However, adult smokers and ex-smokers likely have unique norms towards smoking, and there is no research of which we are aware comparing smoking and vaping norms across countries among youth.

This study therefore assesses whether social norms towards smoking and vaping are associated with country, smoking status, and vaping status among 16--19-year-olds in Canada, England, and the US. At the time of surveying, prevalence of ever smoking and ever vaping among 16--19-year-olds were lowest in Canada but similar in England and the US ([@bib0100]). England and Canada had more comprehensive tobacco control policies than the US, having implemented comprehensive smoke free legislation, retail display bans, bans on tobacco advertising, and mandated graphic health warnings on cigarette packs ([@bib0130]; [@bib0205]). Canada had more restrictive policies on the sale, use, and advertisement of vaping devices than England and the US ([@bib0085]; [@bib0130]), although these were generally unenforced ([@bib0110]).

2. Methods {#sec0010}
==========

2.1. Design {#sec0015}
-----------

A full description of the methods can be found in [@bib0105]). Briefly, data were from Wave 1 (July/August 2017) of the International Tobacco Control Policy Evaluation Project (ITC) Youth Tobacco and Vaping Survey, an online survey of 16--19-year-olds in England, Canada, and US. Respondents were recruited through Nielsen Consumer Insights Global Panel (and partners' panels) directly or through their parents. Email invitations were sent to a random sample of panelists after targeting for age criteria. Panelists not aged 16--19, had no children aged 16--19, and/or were attempting to complete the survey on a mobile device were ineligible to partake. The survey was in English, and French in Canada, and took approximately 15 minutes. The same measures were used in all countries except ethnicity, region, and education, which were based on country census questions. Informed consent was required, and respondents received remuneration according to their panel's incentive structure. Ethical clearance was received from the University of Waterloo Research Ethics Committee (AORE\#21847) and King's College London's Psychiatry, Nursing & Midwifery Research Ethics Subcommittee (PNM-RESC-HR-16/17-4113).

2.2. Sample {#sec0020}
-----------

The survey was completed by 13,468 youth age 16--19-years, of which 10,280 were retained for this study. The following were excluded: those who provided incomplete/invalid data on smoking/vaping status or other variables used for weighting (n = 1120), failed data quality checks (n = 382), did not report or responded "Don't know" to friend smoking (n = 343), friend vaping (n = 309), peer approval of smoking (n = 316), peer approval of vaping (n = 718).

2.3. Measures {#sec0025}
-------------

### 2.3.1. Social norms (outcomes) {#sec0030}

(i)*Friend smoking*: "Who, if anyone... smokes cigarettes?", followed by a list of people. Respondents who checked "Your friend(s)" were coded as having friends who smoke.(ii)*Friend vaping*: "Who, if anyone... uses e-cigarettes/vapes?", followed by a list of people. Respondents who checked "Your friend(s)" were coded as having friends who vape.(iii)*Peer approval of smoking*: "Do people your age approve or disapprove of smoking cigarettes?" (a) Strongly approve, (b) Somewhat approve, (c) Neither approve nor disapprove, (d) Somewhat disapprove, (e) Strongly disapprove. (a)-(b) were coded as approve; (c)-(e) were coded as not approve.(iv)*Peer approval of vaping*: "Do people your age approve or disapprove of using e-cigarettes/vaping?" (a) Strongly approve, (b) Somewhat approve, (c) Neither approve nor disapprove, (d) Somewhat disapprove, (e) Strongly disapprove. (a)-(b) were coded as approve; (c)-(e) were coded as not approve.

Coding of (iii) and (iv) is consistent with similar studies ([@bib0150]; [@bib0065]).

### 2.3.2. Smoking and vaping status {#sec0035}

*Smoking status*: Current (smoked 100+ cigarettes in life and smoked in past-30-days), experimental (tried smoking, but did not smoke 100+ cigarettes in life), former (smoked 100+ cigarettes in life, but did not smoke in past-30-days), never (never tried smoking, not even a puff) ([@bib0105]).

*Vaping status*: Current (vaped 100+ days in life and vaped in past-30-days), experimental (tried vaping, but did not vape 100+ days in life), former (vaped 100+ days in life, but did not vape in past-30-days), never (never tried vaping, not even a puff) ([@bib0105]).

### 2.3.3. Covariates {#sec0040}

Covariates included age (16--19), sex (male, female), ethnicity (white, other/mixed, don't know/refused), current student (yes, no, don't know/refused), monthly alcohol use (yes, no, don't know/refused), past-30-day marijuana use (yes, no, don't know/refused), and two socio-economic status indicators: number of computers in household (0--2, ≥3, don't know/refused), number of bathrooms in household (0--1, ≥2, don't know/refused) ([@bib0115]).

2.4. Analyses {#sec0045}
-------------

All analyses were conducted using Stata v15. First, sample characteristics were examined in each country. Second, prevalence of each social norm was estimated. Third, four separate adjusted logistic regression models were estimated for each social norm to assess associations with country, smoking status, vaping status, and covariates. Fourth, interactions between country and smoking status, and country and vaping status, were added as separate additional steps to the fully-adjusted models. For interactions, experimental and former smokers, and experimental and former vapers, were combined due to low numbers of former smokers and former vapers. Adjusted Wald tests were performed on the interaction terms following model specification; where there was evidence for an interaction (p ≤ .05) average predicted probabilities and pairwise comparisons were generated using Stata's margins command. All analyses use weighted data unless otherwise indicated, with sample weights constructed based on smoking status, region, language (Canada), sex, age, ethnicity, and using a raking algorithm described in [@bib0105].

3. Results {#sec0050}
==========

3.1. Sample characteristics {#sec0055}
---------------------------

Most participants were 18, male, white, students, did not use alcohol monthly (except England), did not use marijuana in the past-30-days, had ≥3 computers and ≥2 bathrooms (except England) in household, and had never smoked or vaped ([Table 1](#tbl0005){ref-type="table"}).Table 1Sample characteristics by country.Table 1Unweighted n (weighted %)England (N = 3444)Canada (N = 3327)US (n = 3509)**Age**16512 (18.82)503 (19.15)736 (22.29)17856 (29.80)775 (27.30)777 (23.54)181226 (30.04)1087 (29.95)1105 (30.48)19850 (21.34)962 (23.59)891 (23.69)**Sex**Male1456 (54.96)1132 (50.90)1376 (53.40)Female1988 (45.04)2195 (49.10)2133 (46.60)**Ethnicity**White2720 (79.57)1818 (59.46)2322 (74.02)Other/mixed696 (19.58)1459 (39.22)1171 (25.54)Don't know/refused28 (0.84)50 (1.32)16 (0.44)**Student**Yes3124 (89.81)3080 (89.76)3121 (86.79)No298 (9.42)239 (9.95)380 (13.09)Don't know/refused22 (0.77)8 (0.29)8 (0.12)**Monthly alcohol use**No1462 (44.64)2011 (63.35)2700 (76.36)Yes1934 (53.93)1254 (34.84)740 (21.55)Don't know/refused48 (1.43)62 (1.81)69 (2.10)**Past-30-day marijuana use**No3088 (88.00)2860 (85.64)2994 (83.05)Yes298 (10.16)416 (12.94)445 (14.46)Don't know/refused58 (1.83)51 (1.42)70 (2.49)**Computers in household**0-2684 (21.58)640 (22.18)960 (30.01)≥32701 (76.73)2644 (76.50)2524 (69.20)DK/refused59 (1.70)43 (1.31)25 (0.78)**Bathrooms in household**0-11753 (53.19)800 (27.73)728 (20.69)≥21671 (46.20)2503 (71.45)2771 (79.01)DK/refused20 (0.61)24 (0.82)10 (0.30)**Smoking status**Never2000 (61.76)2307 (77.63)2317 (58.49)Former26 (1.74)21 (1.63)23 (1.46)Experimental1214 (21.77)857 (8.89)1007 (29.24)Current204 (14.72)142 (11.85)162 (10.80)**Vaping status**Never2266 (64.36)2351 (72.20)2311 (61.72)Former17 (0.96)12 (0.72)27 (1.15)Experimental1115 (31.83)905 (24.03)1084 (32.56)Current46 (2.84)59 (3.04)87 (4.57)

3.2. Prevalence of each social norm {#sec0060}
-----------------------------------

Across all three countries, 46.7% and 51.6% had friends who smoked and vaped respectively. Peer approval of smoking (23.1%) was just over half that of peer approval of vaping (44.3%). Prevalence of smoking and vaping norms in each country is shown in [Table 2](#tbl0010){ref-type="table"}, [Table 3](#tbl0015){ref-type="table"}, respectively.Table 2Adjusted associations between youth reporting that their friends smoke and their friends vape (i.e., descriptive norms) and: country, smoking status, vaping status, and all covariates (n = 10,280). All data are weighted unless otherwise stated.Table 2Unweighted n (% of full sample)Friends smoke (vs. otherwise)Friends vape (vs. otherwise)%AOR (95% CI)p%AOR (95% CI)p**Country**England (ref)3444 (33.1)56.21.0051.61.00Canada3327 (32.3)43.2**0.71 (0.62-0.82)\<.001**50.4**1.17 (1.02-1.36).029**US3509 (34.6)40.8**0.54 (0.47-0.62)\<.001**52.81.10 (0.96-1.27).162**Smoking status**Never (ref)6624 (65.8)33.21.0040.41.00Former70 (1.6)79.5**5.25 (2.57-10.72)\<.001**85.11.50 (0.68-3.33).315Experimental3078 (20.2)63.6**2.62 (2.29-2.99)\<.001**68.5**1.27 (1.10-1.45).001**Current508 (12.4)86.3**8.10 (5.76-11.4)\<.001**79.21.21 (0.89-1.64).226**Vaping status**Never (ref)6928 (66.0)35.61.0035.51.00Former56 (1.0)78.81.68 (0.86-3.26).12887.4**8.47 (2.67-26.93)\<.001**Experimental3104 (29.6)67.0**1.53 (1.34-1.76)\<.001**81.4**6.18 (5.32-7.18)\<.001**Current192 (3.5)75.71.00 (0.63-1.57).99695.6**26.54 (10.59-66.51)\<.001Age**16 (ref)1751 (20.1)38.31.0042.61.00172408 (26.8)42.21.06 (0.91-1.25).45347.0**1.18 (1.01-1.38).037**183418 (30.2)48.51.14 (0.98-1.33).08155.0**1.33 (1.14-1.54)\<.001**192703 (22.9)57.0**1.37 (1.17-1.62)\<.001**60.7**1.44 (1.21-1.70)\<.001Sex**Male (ref)3964 (53.1)47.51.0053.01.00Female6316 (46.9)45.81.05 (0.95-1.17).30750.10.97 (0.87-1.07).505**Ethnicity**White (ref)6860 (71.2)47.91.0051.51.00Other/mixed3326 (28.0)43.9**1.13 (1.01-1.28).041**52.3**1.24 (1.10-1.39)\<.001**Don't know/refused94 (0.9)35.00.86 (0.50-1.48).58442.60.96 (0.55-1.67).874**Student**Yes (ref)9325 (88.8)45.61.0050.51.00No917 (10.9)56.70.87 (0.71-1.05).14560.60.90 (0.73-1.11).313Don't know/refused38 (0.4)24.1**0.18 (0.05-0.69).013**54.01.02 (0.45-2.30).971**Monthly alcohol use**No (ref)6173 (61.7)36.21.0043.91.00Yes3928 (36.6)64.4**1.76 (1.56-1.98)\<.001**64.4**1.43 (1.26-1.62)\<.001**Don't know/refused179 (1.8)44.71.08 (0.71-1.64).72459.81.43 (0.91-2.25).119**Past-30-day marijuana use**No (ref)8942 (85.5)42.21.0047.11.00Yes1159 (12.6)74.6**1.41 (1.15-1.73).001**79.7**1.27 (1.01-1.60).045**Don't know/refused179 (1.9)65.71.48 (1.00-2.21).05172.51.31 (0.89-1.93).168**Computers in household**0-2 (ref)2284 (24.7)50.51.0055.81.00≥37869 (74.1)45.41.04 (0.91-1.18).57950.41.01 (0.89-1.15).879Don't know/refused127 (1.3)45.11.15 (0.70-1.89).59045.00.89 (0.55-1.44).643**Bathrooms in household**0-1 (ref)3281 (33.7)52.01.0053.91.00≥26945 (65.7)44.00.99 (0.88-1.12).92950.50.97 (0.86-1.10).614Don't know/refused54 (0.6)40.81.06 (0.49-2.32).87746.51.28 (0.61-2.68).506[^1]Table 3Adjusted associations between youth perceiving that their peers approve of smoking and their peers approve of vaping (i.e., injunctive norms) and: country, smoking status, vaping status, and all covariates (n = 10,280). All data are weighted unless otherwise stated.Table 3Unweighted n (% of full sample)Peers approve of smoking (vs. not approve)Peers approve of vaping (vs. not approve)%AOR (95% CI)p%AOR (95% CI)p**Country**England (ref)3444 (33.1)25.41.0040.21.00Canada3327 (32.3)21.1**0.74 (0.63-0.87)\<.001**45.6**1.23 (1.08-1.41).002**US3509 (34.6)22.7**0.78 (0.67-0.91).002**47.1**1.30 (1.14-1.48)\<.001Smoking status**Never (ref)6624 (65.8)19.71.0042.71.00Former70 (1.6)28.71.14 (0.61-2.14).68355.10.81 (0.47-1.40).457Experimental3078 (20.2)27.3**1.20 (1.03-1.39).019**47.4**0.82 (0.72-0.93).003**Current508 (12.4)33.8**1.44 (1.09-1.90).011**46.5**0.62 (0.48-0.79)\<.001Vaping status**Never (ref)6928 (66.0)19.11.0039.31.00Former56 (1.0)34.41.84 (0.91-3.72).08847.1**1.98 (1.02-3.83).044**Experimental3104 (29.6)30.4**1.57 (1.34-1.83)\<.001**53.2**2.08 (1.82-2.37)\<.001**Current192 (3.5)34.6**1.81 (1.16-2.81).008**63.8**3.86 (2.53-5.88)\<.001Age**16 (ref)1751 (20.1)22.91.0041.71.00172408 (26.8)23.40.98 (0.82-1.16).78441.20.97 (0.84-1.12).685183418 (30.2)22.4**0.83 (0.70-0.99).036**46.21.11 (0.96-1.28).152192703 (22.9)23.90.84 (0.70-1.02).07447.81.13 (0.97-1.31).131**Sex**Male (ref)3964 (53.1)21.71.0040.91.00Female6316 (46.9)24.7**1.27 (1.13-1.43)\<.001**48.2**1.37 (1.24-1.51)\<.001Ethnicity**White (ref)6860 (71.2)21.21.0042.51.00Other/mixed3326 (28.0)27.9**1.61 (1.41-1.83)\<.001**49.4**1.30 (1.16-1.45)\<.001**Don't know/refused94 (0.9)23.21.23 (0.66-2.27).51133.60.77 (0.45-1.32).350**Student**Yes (ref)9325 (88.8)22.51.0044.01.00No917 (10.9)28.21.21 (0.98-1.49).07547.61.07 (0.89-1.28).460Don't know/refused38 (0.4)29.41.15 (0.48-2.77).75233.20.74 (0.34-1.62).447**Monthly alcohol use**No (ref)6173 (61.7)21.81.0043.81.00Yes3928 (36.6)24.60.95 (0.82-1.10).49345.30.98 (0.87-1.10).712Don't know/refused179 (1.8)36.1**1.75 (1.18-2.59).005**40.00.80 (0.54-1.19).276**Past-30-day marijuana use**No (ref)8942 (85.5)21.61.0043.01.00Yes1159 (12.6)32.8**1.24 (1.00-1.52).047**53.01.11 (0.92-1.34).274Don't know/refused179 (1.9)27.40.94 (0.59-1.48).77644.90.90 (0.59-1.36).604**Computers in household**0-2 (ref)2284 (24.7)27.01.0045.51.00≥37869 (74.1)21.8**0.85 (0.74-0.98).026**44.01.00 (0.89-1.14).964Don't know/refused127 (1.3)26.51.09 (0.61-1.94).76640.81.12 (0.68-1.85).662**Bathrooms in household**0-1 (ref)3281 (33.7)25.21.0045.61.00≥26945 (65.7)22.00.98 (0.86-1.13).82343.7**0.87 (0.78-0.97).016**Don't know/refused54 (0.6)25.70.92 (0.35-2.42).87334.80.74 (0.34-1.61).452[^2]

3.3. Associations between each social norm and country, smoking status, vaping status, and covariates {#sec0065}
-----------------------------------------------------------------------------------------------------

### 3.3.1. Friend smoking {#sec0070}

Respondents had greater odds of reporting that their friends smoke if they were from England (vs. Canada and US), former, experimental or current (vs. never) smokers, experimental (vs. never) vapers, age 19 (vs. 16), other/mixed ethnicity, students (vs. don't know/refused), monthly alcohol users, or past-30-day marijuana users ([Table 2](#tbl0010){ref-type="table"}). Respondents also had greater odds of reporting that their friends smoke if they were from Canada vs. US (AOR = 1.32 \[95% CI = 1.15--1.51\], p \< .001) or were current vs. experimental smokers (AOR = 3.10 \[2.22--4.31\], p \< .001); there was little evidence for any other differences by smoking or vaping status (all p ≥ .055).

### 3.3.2. Friend vaping {#sec0075}

Respondents had greater odds of reporting that their friends vape if they were from Canada (vs. England), experimental (vs. never) smokers, former, experimental or current (vs. never) vapers, age 17--19, other/mixed ethnicity, monthly alcohol users, or past-30-day marijuana users ([Table 2](#tbl0010){ref-type="table"}). Respondents also had greater odds of reporting that their friends vape if they were current vs. experimental vapers (AOR = 4.30 \[1.71--10.80\], p = .002); there was little evidence for any other differences by country, smoking or vaping status (all p ≥ .126).

Post-hoc analyses were used to explore which covariates contributed to higher adjusted odds of friend vaping in Canada compared with England, despite little difference in raw prevalence ([Table 2](#tbl0010){ref-type="table"}). Unadjusted logistic regressions (data not shown) found little evidence for country differences in friend vaping (all p ≥ .103). Excluding smoking and alcohol use from the fully-adjusted model attenuated the difference between Canada and England (all p ≥ .057). Exclusion of other variables did not influence interpretation of results.

### 3.3.3. Peer approval of smoking {#sec0080}

Respondents had greater odds of perceiving that their peers approve of smoking if they were from England (vs. Canada and US), experimental or current (vs. never) smokers, experimental or current (vs. never) vapers, 16 (vs. 18), female, other/mixed ethnicity, did not know or refused to state their monthly alcohol use, were past-30-day marijuana users, or had 0--2 computers in their household ([Table 3](#tbl0015){ref-type="table"}). There was little evidence for any other differences between Canada and US or by smoking or vaping status (all p ≥ .162).

### 3.3.4. Peer approval of vaping {#sec0085}

Respondents had greater odds of perceiving that their peers approve of vaping if they were from Canada or US (vs. England), never (vs. experimental and current) smokers, former, experimental or current (vs. never) vapers, female, other/mixed ethnicity, or had 0--1 bathrooms in their household ([Table 3](#tbl0015){ref-type="table"}). Respondents also had greater odds of perceiving that their peers approve of vaping if they were experimental vs. current smokers (AOR = 1.33 \[1.05--1.69\], p = .017) or were current vs. experimental vapers (AOR = 1.86 \[1.23--2.80\], p = .003). There was little evidence for any other differences between Canada and US or by smoking or vaping status (all p ≥ .080).

3.4. Interactions between country and smoking and vaping status {#sec0090}
---------------------------------------------------------------

### 3.4.1. Friend smoking {#sec0095}

There was little evidence of an interaction between country and smoking (F (4, 10276) = 2.37, p = .0502) or vaping (F (4, 10276) = 2.04, p = .086) status.

### 3.4.2. Friend vaping {#sec0100}

There was an interaction between country and smoking status (F (4,10276) = 6.27, p \< .001; [Fig. 1](#fig0005){ref-type="fig"} (i) (a)). In US, friend vaping was higher among experimental/former (AOR = 1.11 \[1.07--1.16\], p \< .001) and current (AOR = 1.15 \[1.04--1.28\], p = .008) vs. never smokers. There was little evidence of any other differences (all p ≥ .176).Fig. 1Interactions between country (England, Canada, US) and (a) smoking status (never, experimental/former, current), (b) vaping status (never, experimental/former, current) for (i) friend vaping, (ii) peer approval of smoking, and (iii) peer approval of vaping. Predicted probabilities are weighted and adjusted, n = 10,280.Fig. 1

There was also an interaction between country and vaping status (F (4,10276) = 9.64, p \< .001; [Fig. 1](#fig0005){ref-type="fig"} (i) (b)). In England and US, friend vaping was highest among current vapers (vs. experimental/former: England: AOR = 1.29 \[1.19--1.39\], p \< .001; US: AOR = 1.13 \[1.07--1.20\], p \< .001; vs. never: England: AOR = 1.78 \[1.66--1.91\], p \< .001; US: AOR = 1.85 \[1.75--1.95\], p \< .001) followed by experimental/former vapers (vs. never: England: AOR = 1.38 \[1.32--1.45\], p \< .001; US: AOR = 1.63 \[1.57--1.69\], p \< .001). In Canada, friend vaping was higher among experimental/former (AOR = 1.49 \[1.42--1.56\], p \< .001) and current (AOR = 1.59 \[1.35--1.87\], p \< .001) vs. never vapers only (experimental/former vs. current p = .422).

### 3.4.3. Peer approval of smoking {#sec0105}

There was an interaction between country and smoking status (F (4,10276) = 4.74, p = .001; [Fig. 1](#fig0005){ref-type="fig"} (ii) (a)). In England, peer approval of smoking was higher among current vs. experimental/former smokers (AOR = 1.08 \[1.00--1.17\], p = .044). In US, peer approval of smoking was higher among both experimental/former (AOR = 1.08 \[1.04--1.13\], p \< .001) and current (AOR = 1.09 \[1.00--1.19\], p = .042) vs. never smokers. There was little evidence of any other differences (all p ≥ .132).

There was some evidence for an interaction between country and vaping status (F (4,10270) = 2.40, p = .048; [Fig. 1](#fig0005){ref-type="fig"} (ii) (b)). In Canada, peer approval of smoking was higher among experimental/former vs. never vapers (AOR = 1.09 \[1.04--1.15\], p \< .001). In US, peer approval of smoking was higher among experimental/former (AOR = 1.12 \[1.07--1.16\], p \< .001) and current (AOR = 1.15 \[1.02--1.31\], p = .026) vs. never vapers. There was little evidence of any other differences (all p ≥ .075).

### 3.4.4. Peer approval of vaping {#sec0110}

There was an interaction between country and smoking status (F (4,10276) = 8.60, p \< .001; [Fig. 1](#fig0005){ref-type="fig"} (iii) (a)). In England, peer approval of vaping was lowest among current smokers (vs. experimental/former: AOR = 0.93 \[0.87--1.00\], p = .045; vs. never: AOR = 0.83 \[0.78-0.89\], p \< .001) followed by experimental/former smokers (vs. never: AOR = 0.90 \[0.86-0.93\], p \< .001). In Canada, peer approval of vaping was lower among current (AOR = 0.87 \[0.79-0.95\], p = .002) and experimental/former (AOR = 0.92 \[0.87-0.97\], p = .002) vs. never smokers. There was little evidence of any other differences (all p ≥ .201).

There was also an interaction between country and vaping status (F (4,10276) = 5.29, p \< .001; Figure (iii) (b)). In England and Canada, peer approval of vaping was higher among current (England: AOR = 1.27 \[1.06--1.52\], p = .009; Canada: AOR = 1.24 \[1.04--1.47\], p = .016) and experimental/former (England: AOR = 1.13 \[1.08--1.19\], p \< .001; Canada: AOR = 1.16 \[1.10--1.22\], p \< .001) vs. never vapers. In US, peer approval of vaping was highest among current vapers (vs. experimental/former: AOR = 1.20 \[1.09--1.32\], p \< .001; vs. never: AOR = 1.53 \[1.39--1.69\], p \< .001) followed by experimental/former vapers (vs. never: AOR = 1.28 \[1.22--1.34\], p \< .001).

4. Discussion {#sec0115}
=============

This study was the first to our knowledge to assess country differences in social norms towards smoking and vaping among youth and associations with product use. Overall, youth had more pro-vaping than pro-smoking norms. English youth reported the most pro-smoking and least pro-vaping norms overall. Norms were similar in Canada and the US, except more Canadian than US youth reported friend smoking. Smokers had more pro-smoking norms, vapers had more pro-vaping norms, and there were some cross-product associations between norms and use.

Prevalence of friend use of either product was similar overall, with around half of youth reporting friend smoking (47%) and friend vaping (52%), while perceived peer approval of vaping (44%) was almost twice that of peer approval of smoking (23%). Friend smoking and vaping was greater than previous British ([@bib0060]) and US ([@bib0015]; [@bib0080]) studies, possibly due to the older age of participants in this study. To our knowledge, perceived peer approval of smoking and vaping have not been simultaneously assessed in other studies. The finding that peer approval of vaping was greater than smoking is perhaps unsurprising given that vaping is less harmful than smoking ([@bib0160]) and may be more appealing to youth than smoking given the novelty and range of products and flavors available.

The high prevalence of friend product use and perceived peer approval of vaping is concerning, particularly given the age of respondents, that the majority had never smoked or vaped, and that norms were associated with use. There are concerns that the popularity of vaping may lead never smoking youth to try nicotine ([@bib0190]). Between 2017 and 2018, prevalence of vaping increased in Canada and the US, including among never smokers, but did not change in England ([@bib0100]); this mirrors our findings that vaping norms were most positive in the former two countries. It is important that norms are continuously monitored alongside prevalence to explore whether pro-vaping norms could precede any changes in vaping, or smoking.

Friend smoking and peer approval of smoking were more commonly reported by smokers, adding to the large body of evidence that smoking norms influence smoking behavior ([@bib0030]; [@bib0035]; [@bib0050]; [@bib0145]; [@bib0195]). Friend vaping and peer approval of vaping were more commonly reported by vapers, also similar to previous studies ([@bib0080]; [@bib0150]; [@bib0180]). Interestingly, there was a strong dose-response association between greater vaping behavior and pro-vaping norms in all countries which was not mirrored for smoking.

Considering cross-product norm-behavior associations, friend smoking, friend vaping, and peer approval of smoking were more common among smokers and vapers, while peer approval of vaping was more common among vapers but less common among smokers. This suggests that associations between norms and behavior may not be product-specific, although generally product-specific associations were stronger than cross-product associations, particularly for friend smoking and vaping. Except the association between vaping and friend smoking ([@bib0150]; [@bib0165]; [@bib0180]), the direction of associations are inconsistent with previous studies ([@bib0060]; [@bib0150]). This, combined with the mixed positive and negative associations between norms towards one product and use of the alternative, precludes any firm conclusions regarding the potential of e-cigarettes to renormalize smoking. Further research assessing specific norm-behavior pathways using longitudinal methodology is needed.

Both friend smoking and vaping were more common among youth who used alcohol monthly and were older, although increases in friend vaping emerged earlier than friend smoking. Both peer approval of smoking and vaping were more common among females, and generally all norms were more positive among marijuana users (except peer approval of vaping) and ethnic minorities. Thus, there may be some shared risk factors for holding positive smoking and vaping norms.

The country differences in smoking and vaping norms were surprising. English youth reported more pro-smoking norms than the US despite similar smoking rates ([@bib0100]) and the US having less comprehensive tobacco control policies ([@bib0130]; [@bib0210]). Moreover, friend smoking was higher in Canada than the US, yet peer approval of smoking was similar, contrary to Canada's lower smoking prevalence ([@bib0100]; [@bib0200]) and more comprehensive tobacco control policies ([@bib0130]; [@bib0215]). However, the finding that English youth reported more pro-smoking norms than Canadian youth does align with prevalence rates ([@bib0100]; [@bib0200]), Canada's longer history of tobacco control policies ([@bib0095]; [@bib0130]; [@bib0205]) and a recent study among adult daily smokers ([@bib0070]).

Canada and the US had more pro-vaping norms than England in adjusted analyses, while Canada and the US did not differ. However, at the time of surveying, Canada had the lowest vaping prevalence among this age group ([@bib0100]) and the most restrictive vaping policies ([@bib0085]; [@bib0130]). These results may suggest that vaping policies or prevalence rates may have less influence on social norms than some might suppose, reflecting findings from a recent study in Europe ([@bib0065]) yet contrary to findings among adult smokers and ex-smokers in England, Canada, the US, and Australia ([@bib0005]).

The discrepancy between the unadjusted and adjusted country differences in friend vaping warrants further exploration. Despite the adjusted odds of friend vaping being higher in Canada than England, exclusion of smoking and alcohol use attenuated country differences. However, inclusion of alcohol, and marijuana, use is important in studies assessing youth smoking and vaping, since they may serve as a proxy for risky behavior that confounds apparent associations ([@bib0140]).

It is important to mention that while tobacco control policies in 2017 were generally least comprehensive in the US, and vaping policies most restrictive in Canada, the detailed picture is more complicated. Canada's vaping restrictions were generally unenforced ([@bib0110]) and after survey administration Canada implemented a new Vaping Products Act which relaxed many restrictions ([@bib0120]). Further, some youth also use vaping devices for marijuana or cannabis oil ([@bib0025]; [@bib0185]) and around the time of survey administration recreational marijuana use was legalized in Canada and several US states. Both the new Act and marijuana legalization were widely discussed around the time of this survey and may have influenced vaping norms; however, this is only speculation and would be difficult to assess. In addition to national smoking/vaping policies, Canada and the US also have divergent municipal/state/province-level policies (e.g., smoke free legislation, minimum age for legal purchase of nicotine products (US: 18--21; Canada: 18--19)). Moreover, since these data were collected in 2017, vaping environments have changed in Canada and the US: while Canada has relaxed many restrictions ([@bib0120]), the US has launched a national youth vaping prevention campaign ([@bib0075]) and proposed banning vaping in some jurisdictions ([@bib0045]). Youth vaping prevalence has also increased in these two countries since 2017 ([@bib0100]). Therefore, while this study provides an overview of norms in each country, they may differ at the municipal/state/province-level and may not be generalizable to more recent years.

The findings from this study must be considered in light of several limitations. First, data were cross-sectional, meaning that directionality cannot be inferred, and there is almost certainly a reciprocal relationship between norms and behavior. Second, smoking norms may confound vaping norms and vice-versa; for example, some youth could have pro-vaping norms *because* they have anti-smoking norms. Future research could assess within-person differences in smoking/vaping norms and their associations with product use. Third, item wording for friend use does not enable differentiation between those with only one smoking/vaping friend and those among whom all friends smoke/vape. Fourth, data were self-reported and may be subject to recall and social desirability biases, which may be particularly pronounced when asking about peer's nicotine use and norms. However, the fact that this was an anonymous, self-administered survey may alleviate some of this concern. Fifth, as mentioned above, Canada and the US have differing policies at the municipal/state/province-level which were not accounted for in analyses.

Despite these limitations, this study has important strengths. First, although participants were recruited from non-probability-based commercial samples, sample weights were incorporated to enhance representativeness and both weighted and unweighted estimates were similar to national benchmark surveys in each country ([@bib0100]). Second, the sample was large, allowing for assessment of different user status groups and interactions with country. Third, this study is the first to compare social norms towards smoking and vaping and their associations with product use across countries, providing a novel contribution to the literature.

5. Conclusions {#sec0120}
==============

Around half of youth reported having friends who smoke and vape. Perceived peer approval of vaping (44%) was twice that of peer approval of smoking (23%). English youth had the most pro-smoking norms but least pro-vaping norms overall, contrary to regulatory environments. Consistent with previous research, smokers reported more pro-smoking norms while vapers reported more pro-vaping norms. There were also cross-product associations between norms and behavior, although product-specific associations were stronger than cross-product associations.
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[^1]: AOR = Adjusted Odds Ratio. 95% CI = 95% Confidence Interval.
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